Progression of nonmotor symptoms in subgroups of patients with non-dopamine-deficient Parkinsonism.

Abstract

BACKGROUND:

Ten to fifteen percent of Parkinson's disease (PD) patients recruited to clinical trials have scans without evidence of dopaminergic deficit, whose presence represents a heterogeneous patient population.

METHODS:

A cohort of 41 patients with parkinsonism and scans without evidence of dopaminergic deficit at baseline, were subdivided into groups according to their final clinical diagnoses and nigrostriatal dopamine function assessed after 2 years of study. At follow up, 23 patients had clinically probable PD or unclassified parkinsonism with normal nigrostriatal dopamine imaging ("true" scans without evidence of dopaminergic deficit), nine were diagnosed with another tremulous condition, five had psychogenic parkinsonism, and four had phenoconverted to PD with reduced nigrostriatal dopamine function. We analyzed nonmotor symptoms at baseline and follow-up in subgroups of patients with scans without evidence of dopaminergic deficit in comparison with a random sample of 62 PD patients and 195 healthy controls (HCs). All patients were enrolled in the Parkinson's Progressive Marker's Initiative.

RESULTS:

Patients who had true scans without evidence of dopaminergic deficit had more severe rapid eye movement sleep disorder, depression, anxiety, and autonomic dysfunction than HCs in addition to more frequent depressive symptoms and worse cardiovascular dysfunction than patients with PD (P = 0.038, P = 0.047, respectively). Patients with true scans without evidence of dopaminergic deficit had normal olfaction that was significantly better than that of patients with PD (P < 0.001). Subgroup analysis of the cohort with scans without evidence of dopaminergic deficit revealed that all patients shared similar nonmotor features irrespective of their final clinical diagnoses. Follow-up of subject groups showed stable nonmotor symptoms over 2 years of study.

CONCLUSIONS:

At an early symptomatic stage, patients with scans without evidence of dopaminergic deficit and long-standing parkinsonism exhibit nonmotor features that differ from those of patients with PD on mood and cardiovascular and olfactory function, but remain similar to patients with scans without evidence of dopaminergic deficit with alternative final diagnoses.

• Authors: Stuart Taylor, Joseph Gafton, Bina Shah, Gennaro Pagano, K Ray Chaudhuri, David J Brooks, Nicola Pavese
• Journal: Movement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 31 Issue 3 Pg. 344-51 (Mar 2016) ISSN: 1531-8257 [Electronic] United States
• PMID: 26863920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2016 International Parkinson and Movement Disorder Society.

Chemical References

• Dopamine Plasma Membrane Transport Proteins
• Dopamine

Topics

• Adult
• Aged
• Cohort Studies
• Depression (diagnosis, metabolism)
• Depressive Disorder (diagnosis, etiology)
• Dopamine (metabolism)
• Dopamine Plasma Membrane Transport Proteins (metabolism)
• Female
• Humans
• Male
• Middle Aged
• Parkinson Disease (complications, diagnosis, metabolism)
• Tremor (metabolism)